natgillin/translations-raw huggingface dataset:
Italy was designated as evaluating competent authority and submitted the assessment reports together with its recommendations on 20 November 2007 and 10 June 2010.
Italija, ki je bila imenovana za pristojni ocenjevalni organ, je 20. novembra 2007 in 10. junija 2010 predložila poročila o oceni skupaj s svojimi priporočili.
In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014, the opinion of the European Chemicals Agency was formulated on 14 April 2016 by the Biocidal Products Committee, having regard to the conclusions of the evaluating competent authority.
V skladu s členom 7(2) Delegirane uredbe (EU) št. 1062/2014 je Odbor za biocidne pripravke ob upoštevanju ugotovitev pristojnega ocenjevalnega organa 14. aprila 2016 oblikoval mnenje Evropske agencije za kemikalije.
According to that opinion, biocidal products of product-type 8 containing coco alkyltrimethylammonium chloride (ATMAC/TMAC) may be expected to satisfy the requirements of Article 5 of Directive 98/8/EC, provided that certain specifications and conditions concerning their use are complied with.
Glede na navedeno mnenje je za biocidne proizvode 8. vrste proizvodov, ki vsebujejo koko alkiltrimetilamonijev klorid (ATMAC/TMAC), mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES, če so izpolnjene nekatere specifikacije in pogoji glede njihove uporabe.
It is therefore appropriate to approve coco alkyltrimethylammonium chloride (ATMAC/TMAC) for use in biocidal products of product-type 8, subject to compliance with certain specifications and conditions.
Zato je koko alkiltrimetilamonijev klorid (ATMAC/TMAC) primerno odobriti za uporabo v biocidnih proizvodih 8. vrste proizvodov, če je ta v skladu z nekaterimi specifikacijami in pogoji.
Coco alkyltrimethylammonium chloride (ATMAC/TMAC) is approved as an active substance for use in biocidal products of product-type 8, subject to the specifications and conditions set out in the Annex.
Koko alkiltrimetilamonijev klorid (ATMAC/TMAC) se odobri kot aktivna snov za uporabo v biocidnih proizvodih 8. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
EC No: 263-038-9
Št.
CAS No: 61789-18-2
ES: 263-038-9
96,6 % w/w
Št.
30 April 2028
96,6 mas. %
soil and groundwater for wood in service that will be exposed to frequent weathering.
zaradi ugotovljenih tveganj pri ocenjenih uporabah se pri oceni proizvoda posebna pozornost nameni:
In view of the risks identified for soil, surface and ground water, labels and, where provided, safety data sheets of products authorised shall indicate that industrial or professional application shall be conducted within a contained area or on impermeable hard standing with bunding, and that freshly treated timber shall be stored after treatment under shelter or on impermeable hard standing, or both, to prevent direct losses to soil or water, and that any losses from the application of the product shall be collected for reuse or disposal.
industrijskim in poklicnim uporabnikom;
The purity indicated in this column was the minimum degree of purity of the active substance evaluated in accordance with Article 89(1) of Regulation (EU) No 528/2012.
tlom in podtalnici pri gradbenem lesu, ki bo izpostavljen pogostemu preparevanju;
The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.
zaradi ugotovljenih tveganj za tla, površinske vode in podtalnico se na oznakah in po potrebi na varnostnih listih dovoljenih proizvodov navede, da se industrijska ali poklicna uporaba izvaja na zaprtem območju ali na neprepustni trdni podlagi z ogrado in da se sveže tretiran les po tretiranju hrani v zaščitenem prostoru ali na neprepustni trdni podlagi ali oboje, da se preprečijo neposredne izgube v tla ali vodo in da se lahko vse izgube zaradi uporabe proizvoda zberejo za ponovno uporabo ali odstranitev.
Commission Implementing Regulation (EU) 2016/1935
Izvedbena uredba Komisije (EU) 2016/1935
approving calcium dihydroxide (hydrated lime) as an existing active substance for use in biocidal products of product-types 2 and 3
o odobritvi kalcijevega dihidroksida (gašeno apno) kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 2. in 3. vrste proizvodov
That list includes calcium dihydroxide (hydrated lime).
Navedeni seznam vključuje kalcijev dihidroksid (gašeno apno).
Calcium dihydroxide (hydrated lime) has been evaluated in accordance with Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council [3] for use in products of product-type 2, disinfectants and algaecides not intended for direct application to humans or animals, and product-type 3, veterinary hygiene, as described in Annex V to that Directive, which correspond to product-types 2 and 3 respectively, as described in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta [3] je bila opravljena presoja kalcijevega dihidroksida (gašeno apno) glede uporabe v 2. vrsti proizvodov (razkužila in algicidi, ki niso namenjeni neposredni uporabi na ljudeh ali živalih) in 3. vrsti proizvodov (veterinarska higiena), kot sta opredeljeni v Prilogi V k navedeni direktivi in ki ustrezata 2. oziroma 3. vrsti proizvodov iz Priloge V k Uredbi (EU) št. 528/2012.
According to those opinions, biocidal products of product-types 2 and 3 and containing calcium dihydroxide (hydrated lime) may be expected to satisfy the requirements of Article 5 of Directive 98/8/EC, provided that certain specifications and conditions concerning their use are complied with.
Glede na navedena mnenja je za biocidne proizvode 2. in 3. vrste proizvodov, ki vsebujejo kalcijev dihidroksid (gašeno apno), mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES, če so izpolnjene nekatere specifikacije in pogoji za njihovo uporabo.
It is therefore appropriate to approve calcium dihydroxide (hydrated lime) for use in biocidal products of product-types 2 and 3, subject to compliance with certain specifications and conditions.
Zato je kalcijev dihidroksid (gašeno apno) primerno odobriti za uporabo v biocidnih proizvodih 2. in 3. vrste proizvodov, če je ta v skladu z nekaterimi specifikacijami in pogoji.
Calcium dihydroxide (hydrated lime) is approved as an active substance for use in biocidal products of product-types 2 and 3, subject to the specifications and conditions set out in the Annex.
Kalcijev dihidroksid (gašeno apno) se odobri kot aktivna snov za uporabo v biocidnih proizvodih 2. in 3. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
Calcium dihydroxide (hydrated lime)
Kalcijev dihidroksid (gašeno apno)
EC No: 215-137-3
Št.
CAS No: 1305-62-0
ES: 215-137-3
(the value provides the content of Ca expressed as Ca(OH)2)
Št.
30 April 2028
(vrednost navaja vsebnost Ca, izraženo kot Ca(OH)2)
Commission Implementing Regulation (EU) 2016/1936
Izvedbena uredba Komisije (EU) 2016/1936
approving calcium oxide (burnt lime) as an existing active substance for use in biocidal products of product-types 2 and 3
o odobritvi kalcijevega oksida (žganega apna) kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 2. in 3. vrste proizvodov
That list includes calcium oxide (burnt lime).
Navedeni seznam vključuje kalcijev oksid (žgano apno).
Calcium oxide (burnt lime) has been evaluated in accordance with Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council [3] for use in products of product-type 2, disinfectants and algaecides not intended for direct application to humans or animals, and product-type 3, veterinary hygiene, as described in Annex V to that Directive, which correspond to product-types 2 and 3 respectively, as described in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta [3] je bila opravljena presoja kalcijevega oksida (žganega apna) glede uporabe v 2. vrsti proizvodov (razkužila in algicidi, ki niso namenjeni neposredni uporabi na ljudeh ali živalih) in 3. vrsti proizvodov (veterinarska higiena), kot sta opredeljeni v Prilogi V k navedeni direktivi in ki ustrezata 2. oziroma 3. vrsti proizvodov iz Priloge V k Uredbi (EU) št. 528/2012.
According to those opinions, biocidal products of product-types 2 and 3 and containing calcium oxide (burnt lime) may be expected to satisfy the conditions of Article 5 of Directive 98/8/EC, provided that certain specifications and conditions concerning their use are complied with.
Glede na navedena mnenja je za biocidne proizvode 2. in 3. vrste proizvodov, ki vsebujejo kalcijev oksid (žgano apno), mogoče pričakovati, da izpolnjujejo pogoje iz člena 5 Direktive 98/8/ES, če so izpolnjene nekatere specifikacije in pogoji glede njihove uporabe.
It is therefore appropriate to approve calcium oxide (burnt lime) for use in biocidal products of product-types 2 and 3, subject to compliance with certain specifications and conditions.
Zato je kalcijev oksid (žgano apno) primerno odobriti za uporabo v biocidnih proizvodih 2. in 3. vrste proizvodov, če je ta v skladu z nekaterimi specifikacijami in pogoji.
Calcium oxide (burnt lime) is approved as an active substance for use in biocidal products of product-types 2 and 3, subject to the specifications and conditions set out in the Annex.
Kalcijev oksid (žgano apno) se odobri kot aktivna snov za uporabo v biocidnih proizvodih 2. in 3. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
Calcium oxide (burnt lime)
Kalcijev oksid (žgano apno)
EC No: 215-138-9
Št.
CAS No: 1305-78-8
ES: 215-138-9
(The value provides the content of Ca expressed as CaO)
Št.
30 April 2028
(vrednost navaja vsebnost Ca, izraženo kot CaO)
Commission Implementing Regulation (EU) 2016/1937
Izvedbena uredba Komisije (EU) 2016/1937
approving cyfluthrin as an existing active substance for use in biocidal products of product-type 18
o odobritvi ciflutrina kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 18. vrste proizvodov
That list includes cyfluthrin.
Navedeni seznam vključuje ciflutrin.
Cyfluthrin has been evaluated in accordance with Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council [3] for use in products of product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that Directive, which corresponds to product-type 18 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta [3] je bila opravljena ocena ciflutrina glede uporabe v proizvodih 18. vrste proizvodov (insekticidi, akaricidi in proizvodi za nadzor drugih členonožcev), kot je opredeljena v Prilogi V k navedeni direktivi, kar ustreza 18. vrsti proizvodov, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
Germany was designated as evaluating competent authority and submitted the assessment report together with its recommendations on 23 December 2010.
Nemčija, ki je bila imenovana za pristojni ocenjevalni organ, je 23. decembra 2010 predložila poročilo o oceni, skupaj s svojimi priporočili.
In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014, the opinion of the European Chemicals Agency was formulated on 16 February 2016 for use in products of product-type 18 by the Biocidal Products Committee, having regard to the conclusions of the evaluating competent authority.
V skladu s členom 7(2) Delegirane uredbe (EU) št. 1062/2014 je Odbor za biocidne pripravke ob upoštevanju ugotovitev pristojnega ocenjevalnega organa 16. februarja 2016 oblikoval mnenje Evropske agencije za kemikalije o uporabi v proizvodih 18. vrste proizvodov.
According to that opinion, biocidal products of product-type 18 containing cyfluthrin may be expected to satisfy the requirements of Article 5 of Directive 98/8/EC, provided that certain specifications and conditions concerning their use are complied with.
Iz njega je razvidno, da je za biocidne proizvode 18. vrste proizvodov, ki vsebujejo ciflutrin, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES, če so izpolnjene nekatere specifikacije in nekateri pogoji glede njihove uporabe.
It is therefore appropriate to approve cyfluthrin for use in biocidal products of product-type 18, subject to compliance with certain specifications and conditions.
Zato je primerno ciflutrin odobriti za uporabo v biocidnih proizvodih 18. vrste proizvodov, pod pogojem, da je to v skladu z nekaterimi specifikacijami in pogoji.
Cyfluthrin is approved as an active substance for use in biocidal products of product-type 18, subject to the specifications and conditions set out in the Annex.
Ciflutrin se odobri kot aktivna snov za uporabo v biocidnih proizvodih 18. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
(RS)-α-Cyano-4-fluoro-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
(RS)-α-ciano-4-fluoro-3-fenoksibenzil (1RS,3RS;1RS,3SR)-3-(2,2-diklorovinil)-2,2-dimetilciklopropankarboksilat
EC No: 269-855-7
Št.
CAS No: 68359-37-5
ES: 269-855-7
28 February 2028
1. marec 2018
The authorisations of biocidal products are subject to the following conditions:
28. februar 2028
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.
Dovoljenja za biocidne proizvode se izdajo pod naslednjimi pogoji:
In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to:
pri oceni proizvoda je treba posebno pozornost nameniti vidikom izpostavljenosti, tveganja in učinkovitosti, povezanim s katero koli uporabo, zajeto v vlogi za izdajo dovoljenja, ki pa ni bila obravnavana v oceni tveganja aktivne snovi na ravni Unije;
surface water and sediment for products used in domestic premises and animal housing with release to a sewage treatment plant;
zaradi ugotovljenih tveganj v zvezi z ocenjenimi uporabami se pri oceni proizvoda posebna pozornost nameni predvsem:
surface water and sediment for products used in animal housing with direct release to surface water;
površinskim vodam in usedlinam pri proizvodih, ki se uporabljajo v hišnih prostorih in bivalnih prostorih za živali ter odtekajo v naprave za čiščenja odpadnih voda;
surface water and sediment after manure application on agricultural soil for products used in animal housings.
površinskim vodam in usedlinam pri proizvodih, ki se uporabljajo v bivalnih prostorih za živali in neposredno odtekajo v površinske vode;
For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council [2] or Regulation (EC) No 396/2005 of the European Parliament and of the Council [3] shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded.
površinskim vodam in usedlinam po uporabi gnoja na kmetijskih površinah za proizvode, ki se uporabljajo v bivalnih prostorih za živali;
The purity indicated in this column was the minimum degree of purity of the active substance evaluated in accordance with Article 89(1) of Regulation (EU) No 528/2012.
za proizvode, ki lahko povzročajo ostanke v živilih ali krmi, se preveri, ali je treba določiti nove ali spremeniti obstoječe mejne vrednosti ostankov (MRL) v skladu z Uredbo (ES) št. 470/2009 Evropskega parlamenta in Sveta [2] ali Uredbo Evropskega parlamenta in Sveta (ES) št. 396/2005 [3], in sprejmejo vsi ustrezni ukrepi za zmanjšanje tveganja, da se veljavne mejne vrednosti ostankov ne presežejo.
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
Čistost, navedena v tem stolpcu, je bila minimalna stopnja čistosti aktivne snovi, ocenjene v skladu s členom 89(1) Uredbe (EU) št. 528/2012.
Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (OJ L 152, 16.6.2009, p. 11).
Čistost aktivne snovi v proizvodu, danem na trg, je lahko enaka ali drugačna, če je dokazano tehnično enakovredna aktivni snovi iz ocene.
Commission Implementing Regulation (EU) 2016/1938
Izvedbena uredba Komisije (EU) 2016/1938
approving citric acid as an existing active substance for use in biocidal products of product-type 2
o odobritvi citronske kisline kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 2. vrste proizvodov
That list includes citric acid.
Navedeni seznam vključuje citronsko kislino.
Citric acid has been evaluated in accordance with Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council [3] for use in products of product-type 1, human hygiene biocidal products, as defined in Annex V to that Directive, which corresponds to product-type 1 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta je bila opravljena ocena citronske kisline [3] glede uporabe v proizvodih 1. vrste proizvodov, biocidnih proizvodih za človekovo osebno higieno, kot je opredeljena v Prilogi V k navedeni direktivi, ki ustreza 1. vrsti proizvodov, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
However, the evaluation covered an anti-viral tissue impregnated with citric acid which would be placed on the market with the claim ‘kills 99,9 % of cold & flu viruses in the tissue’.
Vendar je ocena obravnavala protivirusne robčke, impregnirane s citronsko kislino, ki bi bili dani na trg s trditvijo „ubijejo 99,9 % virusov prehlada in gripe na robčkih“.
In accordance with Article 1 of Commission Implementing Decision (EU) 2015/1985 [4], such anti-viral tissue is to be considered as a biocidal product falling within product-type 2 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 1 Izvedbenega sklepa Komisije (EU) 2015/1985 [4] je treba tovrstne protivirusne robčke obravnavati kot biocidne proizvode, ki spadajo v 2. vrsto proizvodov, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
Therefore, this approval of citric acid as an existing active substance should only cover its use in biocidal products of product-type 2, disinfectants and algaecides not intended for direct application to humans or animals.
Zato bi morala ta odobritev citronske kisline kot obstoječe aktivne snovi zajemati samo njeno uporabo v biocidnih proizvodih 2. vrste proizvodov (razkužila in algicidi, ki niso namenjeni neposredni uporabi na ljudeh ali živalih).
Belgium was designated as evaluating competent authority and submitted the assessment report together with its recommendations on 23 August 2013.
Belgija, ki je bila imenovana za pristojni ocenjevalni organ, je 23. avgusta 2013 predložila poročilo o oceni, skupaj s svojimi priporočili.
In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014, the opinion of the European Chemicals Agency was formulated on 16 February 2016 for use in products of product-type 2 by the Biocidal Products Committee, having regard to the conclusions of the evaluating competent authority.
V skladu s členom 7(2) Delegirane uredbe (EU) št. 1062/2014 je Odbor za biocidne pripravke ob upoštevanju ugotovitev pristojnega ocenjevalnega organa 16. februarja 2016 oblikoval mnenje Evropske agencije za kemikalije za uporabo v proizvodih 2. vrste proizvodov.
According to that opinion, biocidal products of product-type 2 containing citric acid may be expected to satisfy the requirements of Article 5 of Directive 98/8/EC, provided that certain specifications and conditions concerning their use are complied with.
Iz njega je razvidno, da je za biocidne proizvode 2. vrste proizvodov, ki vsebujejo citronsko kislino, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES, če so izpolnjene določene specifikacije in pogoji glede njihove uporabe.
It is therefore appropriate to approve citric acid for use in biocidal products of product-type 2, subject to compliance with certain specifications and conditions.
Zato je primerno citronsko kislino odobriti za uporabo v biocidnih proizvodih 2. vrste proizvodov, pod pogojem, da je to v skladu z določenimi specifikacijami in pogoji.
Citric acid is approved as an active substance for use in biocidal products of product-type 2, subject to the specifications and conditions set out in the Annex.
Citronska kislina se odobri kot aktivna snov za uporabo v biocidnih proizvodih 2. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
Commission Implementing Decision (EU) 2015/1985 of 4 November 2015 pursuant to Article 3(3) of Regulation (EU) No 528/2012 of the European Parliament and of the Council on an anti-viral tissue impregnated with citric acid (OJ L 289, 5.11.2015, p. 26).
Izvedbeni sklep Komisije (EU) 2015/1985 z dne 4. novembra 2015 v skladu s členom 3(3) Uredbe (EU) št. 528/2012 Evropskega parlamenta in Sveta o protivirusnih robčkih, impregniranih s citronsko kislino (UL L 289, 5.11.2015, str. 26).
ydroxy-1,2,3-propanetricarboxylic acid
idroksi-1,2,3-propantrikarboksilna kislina
EC No: 201-069-1
Št.
CAS No: 77-92-9
ES: 201-069-1
1 March 2018
Št.
The authorisations of biocidal products are subject to the following condition:
1. marec 2018
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.
28. februar 2028
The purity indicated in this column was the minimum degree of purity of the active substance evaluated in accordance with Article 89(1) of Regulation (EU) No 528/2012.
Dovoljenja za biocidne proizvode se izdajo pod naslednjim pogojem:
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
Pri oceni proizvoda je treba posebno pozornost nameniti vidikom izpostavljenosti, tveganja in učinkovitosti, povezanim s katero koli uporabo, zajeto v vlogi za izdajo dovoljenja, ki pa ni bila obravnavana v oceni tveganja aktivne snovi na ravni Unije.
Commission Implementing Regulation (EU) 2016/1939
Izvedbena uredba Komisije (EU) 2016/1939
Commission Implementing Regulation (EU) 2016/1947
Izvedbena uredba Komisije (EU) 2016/1947
approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (Tome des Bauges (PDO))
o odobritvi spremembe specifikacije za ime, vpisano v registru zaščitenih označb porekla in zaščitenih geografskih označb, ki ni manjša (Tome des Bauges (ZOP))
Pursuant to the first subparagraph of Article 53(1) of Regulation (EU) No 1151/2012, the Commission has examined France's application for the approval of amendments to the specification for the protected designation of origin ‘Tome des Bauges’ registered under Commission Regulation (EC) No 503/2007 [2].
Komisija je v skladu s prvim pododstavkom člena 53(1) Uredbe (EU) št. 1151/2012 preučila zahtevek Francije za odobritev spremembe specifikacije za zaščiteno označbo porekla „Tome des Bauges“, registrirano v skladu z Uredbo Komisije (ES) št. 503/2007 [2].